US 11596635
Pharmaceutical compositions comprising macrolide diastereomers, methods of their synthesis and therapeutic uses
granted A61KA61K31/5365A61K31/537
Quick answer
US patent 11596635 (Pharmaceutical compositions comprising macrolide diastereomers, methods of their synthesis and therapeutic uses) held by REGENERON PHARMACEUTICALS, INC. expires Mon Mar 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Mar 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/5365, A61K31/537, A61K45/06, A61K47/68033